Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity-Reference-Cited by-同舟云学术

Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity

Published:2013-02-28 Issue:2 Volume:8 Page:e57479
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Sampei Zenjiro,Igawa Tomoyuki,Soeda Tetsuhiro,Okuyama-Nishida Yukiko,Moriyama Chifumi,Wakabayashi Tetsuya,Tanaka Eriko,Muto Atsushi,Kojima Tetsuo,Kitazawa Takehisa,Yoshihashi Kazutaka,Harada Aya,Funaki Miho,Haraya Kenta,Tachibana Tatsuhiko,Suzuki Sachiyo,Esaki Keiko,Nabuchi Yoshiaki,Hattori Kunihiro

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference48 articles.

1. Practice patterns in haemophilia A therapy - global progress towards optimal care;S Geraghty;Haemophilia,2006

2. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia;MJ Manco-Johnson;N Engl J Med,2007

3. Survey of current prophylaxis practices and bleeding characteristics of children with severe haemophilia A in US haemophilia treatment centres;MV Ragni;Haemophilia,2012

4. Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight;S Bjorkman;Blood,2012

5. Intravascular recovery of VWF and FVIII following intraperitoneal injection and differences from intravenous and subcutaneous injection in mice;Q Shi;Haemophilia,2012

Cited by 266 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Progresses and Challenges of Bispecific Antibodies for the Treatment of Solid Tumors;Molecular Diagnosis & Therapy;2024-08-22

2. Final Analysis Results from the AGEHA Study: Emicizumab Prophylaxis for Acquired Hemophilia A with or without Immunosuppressive Therapy;Thrombosis and Haemostasis;2024-08-12

3. Comprehensive Stress Stability Studies Reveal the Prominent Stability of the Liquid-Formulated Biotherapeutic Asymmetric Monovalent Bispecific IgG1 Monoclonal Antibody Format;Journal of Pharmaceutical Sciences;2024-08

4. Therapeutic potential of cis-targeting bispecific antibodies;Cell Chemical Biology;2024-08

5. Structural study of a light chain mispaired bispecific predicts mechanism of downstream separation;Journal of Chromatography A;2024-08